Coeptis Therapeutics, Inc. (COEP)
USD 9.75
(2.85%)
USD 9.75
(2.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -1 Million USD | 0.01% |
| 2022 | -1 Million USD | -168.89% |
| 2021 | -372.41 Thousand USD | 60.1% |
| 2020 | -933.45 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -250.21 Thousand USD | 0.0% |
| 2024 Q1 | -250.21 Thousand USD | -119.99% |
| 2023 Q2 | -250.3 Thousand USD | 0.0% |
| 2023 Q1 | -250.3 Thousand USD | 0.01% |
| 2023 FY | -1 Million USD | 0.01% |
| 2023 Q4 | 1.25 Million USD | 600.0% |
| 2023 Q3 | -250.3 Thousand USD | 0.0% |
| 2022 Q4 | -250.34 Thousand USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 FY | -1 Million USD | -168.89% |
| 2021 Q3 | 8396.00 USD | 0.0% |
| 2021 FY | -372.41 Thousand USD | 60.1% |
| 2021 Q1 | 75 Thousand USD | 0.0% |
| 2021 Q2 | - USD | -100.0% |
| 2021 Q4 | - USD | -100.0% |
| 2020 FY | -933.45 Thousand USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | -40951.087% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 108.553% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -213.369% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.841% |
| Qrons Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 96.119% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -1974.714% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -705.817% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 106.675% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 32377.112% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 110.223% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 1623.302% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -2831.877% |
| Mesoblast Limited | -35.16 Million USD | 97.153% |
| Marizyme, Inc. | 457.7 Thousand USD | 318.753% |
| Genus plc | 178.7 Million USD | 100.56% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.455% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 1709.032% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 344.106% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -9002.145% |
| ContraFect Corporation | -154 Thousand USD | -550.153% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -1902.472% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 1404.355% |
| IMV Inc. | -962.29 Thousand USD | -4.046% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -158.383% |
| MultiCell Technologies, Inc. | 49.32 USD | 2030181.103% |
| ONE Bio Corp. | 20.12 Million USD | 104.975% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 102.487% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 2147.517% |
| Q BioMed Inc. | -8988.00 USD | -11039.697% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 103.544% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | -6391.416% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 102.257% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 12.293% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 1530.337% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -20118.821% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 812.623% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -926.751% |
| GB Sciences, Inc. | -624.00 USD | -160354.487% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -1063.849% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.013% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -481263.462% |
| Enzolytics Inc. | 30.7 Thousand USD | 3360.505% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 307.539% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.09% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | -94.6% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 262.174% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.244% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -11205.736% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -1094.094% |
| Kadimastem Ltd | -630.13 Thousand USD | -58.892% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 201.342% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 110.418% |
| BioStem Technologies, Inc. | 15.42 Million USD | 106.491% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -8359.958% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 667.08% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 667.08% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 173.775% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | -3352.538% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 322.476% |
| SYBLEU INC | 11.69 Thousand USD | 8660.499% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 121.728% |
| Bioxytran, Inc. | -8285.00 USD | -11984.925% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -168.428% |
| Neutra Corp. | 14.33 Thousand USD | 7084.555% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -1121.02% |
| PureTech Health plc | -1.6 Million USD | 37.54% |
| IXICO plc | 3.27 Million USD | 130.619% |
| IntelGenx Technologies Corp. | -694 Thousand USD | -44.27% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 44.096% |
| CSL Limited | 7.7 Billion USD | 100.013% |
| Cellectis S.A. | 18 Thousand USD | 5662.422% |